Table 5 The cumulative incidence of EBV infection in patients post-HSCT by risk group
Risk group | score | Derivation cohort | Validation cohort | All patients |
|---|---|---|---|---|
low | 0–3 | 21/183 (11.5%) | 30/163 (18.4%) | 51/347 (14.7%) |
intermediate | 5–6 | 17/53 (32.1%) | 11/48 (22.9%) | 28/101 (27.7%) |
high | 8–11 | 10/13 (76.9%) | 6/6 (100%) | 16/19 (84.2%) |